Analysts: Clovis Oncology Inc (CLVS.OQ)

CLVS.OQ on NASDAQ Stock Exchange Global Select Market

77.36USD
1 Aug 2013
Price Change (% chg)

$-0.52 (-0.67%)
Prev Close
$77.88
Open
$79.25
Day's High
$81.75
Day's Low
$74.03
Volume
135,728
Avg. Vol
103,511
52-wk High
$86.29
52-wk Low
$11.19

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.64 December 2 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 4 3 2 2
(3) HOLD 0 0 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.80 1.75 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 4 0.00 0.00 0.00 --
Quarter Ending Dec-13 4 0.00 0.00 0.00 --
Year Ending Dec-13 4 0.00 0.00 0.00 0.00
Year Ending Dec-14 4 0.00 0.00 0.00 127.70
Earnings (per share)
Quarter Ending Sep-13 4 -0.64 -0.54 -0.77 --
Quarter Ending Dec-13 4 -0.71 -0.56 -0.90 --
Year Ending Dec-13 5 -2.67 -2.23 -3.11 -2.39
Year Ending Dec-14 5 -3.37 -2.88 -3.81 -1.04

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 0.00 0.00 0.00 0.00
Quarter Ending Dec-12 0.00 0.00 0.00 0.00
Quarter Ending Sep-12 0.00 0.00 0.00 0.00
Quarter Ending Jun-12 0.00 0.00 0.00 0.00
Quarter Ending Mar-12 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 0.00 0.00 0.00 0.00 --
Quarter Ending Dec-13 0.00 0.00 0.00 0.00 --
Year Ending Dec-13 0.00 0.00 0.00 0.00 0.00
Year Ending Dec-14 0.00 0.00 0.00 33.88 127.70

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Dec-13 0 0 0 0
Year Ending Dec-14 0 0 0 0
Earnings

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks